Michael Malone

Michael has over 20 years of experience working in the pharmaceutical industry having roles of increasing responsibility across the entire value chain. He has held a number of Senior Executive positions in his career including more recently as Vice President, Global Head of Enterprise Risk Management at UCB Biopharma. Michael designed, implemented and led the new Enterprise Risk Management program at UCB and chaired the Corporate Risk Management Committee. Michael is also the CEO and founder of a risk and regulatory (R&R) consultancy firm focused on supporting large global companies across different sectors including healthcare.

Education

• INSEAD - Executive MBA Program, (Transition to General Management, formerly International Executive Program) 2012 - 2013

• Harvard Business School - Multiple Senior Leadership Programs (Negotiations, Finance, Leadership, Corporate Risk/ ERM) 2005 - 2017

• Dublin City University - PhD, Electrochemical detection systems/ diagnostics 1991 - 1994

• Dublin City University - Postdoctoral Fellowship in Diagnostics (uTAS) Research (DCU and Ciba-Geigy Ltd.)

• Harvard Business School - Risk Management for Corporate Executives, Enterprise Risk Management 2017 - 2017

• The Tuck School of Business at Dartmouth - Executive Leadership Program 2009 - 2009

• INSEAD - Certificate in Global Management, Business Administration and Management, General 2016 - 2016

• INSEAD - Leading Successful Change, Business Administration and Management, General 2015 - 2015

• Solvay Brussels School - Associate Lecturer, Enterprise Risk Management, Organisational Resilience 2020